查找临床试验
已按「胃癌」检索，对应国际通用词 gastric cancer
共找到 359 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 22:08，每 5 分钟自动同步Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)
China
年龄 18 Years – 不限
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer
China
年龄 18 Years – 不限
Sanofi
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
China
年龄 18 Years – 不限
Weijia Fang, MD
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer
China
年龄 18 Years – 75 Years
Fudan University
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
China
年龄 18 Years – 不限
Beijing Tide Pharmaceutical Co., Ltd
A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique
China
年龄 18 Years – 75 Years
Huashan Hospital
AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer
China
年龄 18 Years – 75 Years
Harbin Medical University
Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer
China
年龄 18 Years – 75 Years
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
China
年龄 18 Years – 80 Years
Beijing Friendship Hospital
Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer
China
年龄 18 Years – 70 Years
Fudan University
SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer
China
年龄 18 Years – 不限
The First Affiliated Hospital with Nanjing Medical University
Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors
China
年龄 18 Years – 不限
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.